Share

EORTC presentations at ESMO World Congress on Gastrointestinal Cancer

The EORTC will present one oral abstract and one poster abstract at the 17th ESMO World Congress on Gastrointestinal Cancer which will be held 01 – 04 July 2015 in Barcelona.

Poster P-310

carmela-caballeroC. Caballero, S. Evrard, G. Poston
EORTC 1409-GITCG CLIMB: An EORTC-ESSO Prospective Colorectal Liver Metastasis Database with an Integrated Quality Assurance Program
Friday, 3 July from 10:25 to 10:55 and 16:30 to 17:00
Citation: Ann Oncol (2015) 26 (suppl 4): iv91

Oral Abstract O-018

Theo-RuersT. Ruers, C.J.A. Punt, F. van Coevorden, J.-P. Pierie, I. Borel Rinkes, J. Ledermann, G. Poston, W. Bechstein, M.-A. Lentz, M. Mauer, E. Van Cutsem, M. Lutz, B. Nordlinger
Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
July 2015
Citation: Ann Oncol (2015) 26 (suppl 4): iv114-iv115

Follow on Twitter  #WorldGI, #EORTC

Back to news list

Related News

  • EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients

  • Pink October at EORTC: Over 60 years of impactful breast cancer research

  • Spotlight on ENA 2024 News

  • Do regulations and policies undermine the social value of independent academic research?

  • EORTC Quality of Life Group’s participation to ISOQOL 2024

  • New Insights into Glioblastoma Treatment for Older Adults Patients

  • TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival

  • New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024

  • Late Breaking Results from the EORTC 1333/PEACE III phase III trial

  • EORTC’s presence at ESMO 2024